Lupin jumps after its arm incorporates wholly owned subsidiary in New Zealand

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 2062.00, up by 69.30 points or 3.48% from its previous closing of Rs. 1992.70 on the BSE. The scrip opened at Rs. 2014.00 and has touched a high and low of Rs. 2066.30 and Rs. 2004.00 respectively. So far 72851 shares were traded on the counter. The BSE group … Read more

BREAKING NEWS:
Jio’s Exciting 3 Plans: Unlimited Calling and Data for 90 Days! Thousands of Electric Cars Sold in May: Top 5 Revealed Big iPhone 17 Pro deal: Amazon Sale starts July 4!